Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCL161 Alone and with Cyclophosphamide in Relapsed/Refractory Multiple Myeloma
NCT01955434Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LCL161 in multiple myeloma (MM), sponsored by Mayo Clinic. Started Nov 2013; status: completed.
02
Drugs
LCL161
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01955434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955434.